Clonazepam, an anxiety drug, has been recalled because of a labeling error that could result in harmful consequences.

"Clonazepam Orally Disintegrating Tablets, USP (C-IV)" on November 18th, due to "potential product carton strength ...

Endo USA has expanded its voluntary recall of clonazepam orally disintegrating tablets due to a mislabeling issue that could lead to patients accidentally ingesting the wrong dosage.

Drug maker Endo, Inc. issued a recall for tablets of clonazepam, the generic for Klonopin. Cartons of the company’s "Orally ...

The company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.

Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life ...

A medication used to treat seizures and panic disorders has been recalled after learning that the medication was twice as ...

Endo, Inc., has expanded its voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to mislabeled ...

At least 15 people in Minnesota have been sickened by E. coli poisoning tied to a national recall of more than 167,000 pounds ...

The agency warned that adults and children who inadvertently took a higher dose of clonazepam than prescribed could ...

The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.